Prostamax for Prostate Health & Male Urogenital Support — Bioregulators
Khavinson bioregulator peptide for prostate tissue regeneration and male urogenital system optimization.
Overview
Prostamax is a Khavinson bioregulator specifically designed for prostate health and male urogenital system support. Through DNA-level gene regulation in prostate tissues, Prostamax promotes tissue repair, supports urinary function, and optimizes prostate aging. It's particularly valuable for benign prostatic hyperplasia (BPH), prostate aging, urinary symptoms, and male reproductive health maintenance.
Indications
- Benign prostatic hyperplasia (BPH) support
- Prostate tissue health and aging
- Urinary flow and function optimization
- Prostate inflammation support
- Male reproductive health in aging
- Post-prostatitis recovery
- Urogenital system health maintenance
Mechanism of Action
Age-related prostate enlargement, urinary obstruction, or prostate inflammation
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Prostamax | 20 mg | Once daily | Prostate health maintenance and BPH support |
| Prostamax | 20 mg | Twice daily for first 2 months, then once daily | For BPH or urinary symptoms |
Evidence Grade
GRADE C
Safety & Contraindications
- Emerging evidence - Russian urology studies
- No reported adverse effects in clinical trials
- Not a replacement for BPH or prostate medications
- Monitor PSA levels if history of prostate concerns
- Consult urologist with prostate disease or elevated PSA
- Contraindicated in prostate cancer without oncologist approval
- Safe for long-term prostate health support